Legionella pneumophila

Back to all microorganisms

High Bacteria Gram-negative bacteria

SEQ Medical assessment

Risk rating
High
Comments
Water-system pathogen. Not a routine AER final rinse target, but any healthcare water detection should be escalated.
Suggested action
Urgent investigation. Review water system, biofilm risk, filtration, stagnation, deadlegs and recent maintenance.

Legionella pneumophila is a fastidious, aerobic Gram-negative bacillus and the principal agent of legionellosis. It is a natural inhabitant of fresh water, where it survives and multiplies intracellularly within free-living amoebae and other protozoa and persists within multi-species biofilm. In the built environment it colonises engineered water systems, amplifying in warm water, in stagnant sections, in scale and sediment, and where residual disinfectant is depleted. Growth is favoured across a temperature band spanning roughly 25 to 45 degrees Celsius, which is why control strategies concentrate on keeping cold water genuinely cold and hot water genuinely hot, and on eliminating the lukewarm intermediate conditions created by long runs, poor insulation, oversized storage and infrequently used outlets.

The intracellular relationship with protozoa is central to the organism’s behaviour and distinguishes it from most other waterborne bacteria of healthcare concern. Amoebae grazing on biofilm ingest Legionella, which then replicates within the host cell and is released in large numbers, sometimes packaged in vesicles that are both highly infectious and substantially protected from disinfectants. Control measures that do not address the protozoan and biofilm component of the system will suppress planktonic counts temporarily without removing the amplification mechanism.

Infection follows inhalation or aspiration of aerosols or water containing the organism. Legionellosis takes two forms: Legionnaires’ disease, a severe pneumonia, and Pontiac fever, a self-limiting febrile illness without pneumonia. Risk is elevated in older adults, smokers, people with chronic lung disease, and immunocompromised patients, particularly transplant recipients and those on corticosteroids, which makes healthcare facilities a setting of particular concern. Healthcare-associated cases carry higher mortality than community-acquired cases, reflecting the underlying condition of the patients exposed. Diagnosis relies on urinary antigen testing, which detects only L. pneumophila serogroup 1, together with culture and molecular methods, so a facility relying on urinary antigen alone will under-detect infection caused by other serogroups and species.

Associated infections

  • Legionnaires' disease (severe pneumonia)
  • Pontiac fever
  • Extrapulmonary legionellosis, including endocarditis, prosthetic valve infection and wound infection (rare)

Transmission route

Transmission occurs through inhalation of contaminated aerosols or through aspiration of contaminated water; person-to-person spread is not a recognised route, and a single probable case of person-to-person transmission reported internationally remains an isolated exception rather than a basis for infection control practice. Devices and systems capable of generating exposure include showers and taps, cooling towers, decorative fountains, hot and cold water distribution systems, humidifiers, hydrotherapy equipment, ice machines and respiratory therapy devices filled with non-sterile water. Aspiration is a particularly important route in healthcare, affecting patients with impaired swallowing, those receiving enteral feeding, and those whose oral care or medication administration involves tap water.

Health authorities recommend that healthcare facilities operate a documented water management program covering identification of amplification and exposure points, control limits, monitoring and defined intervention when results are out of specification. Such a program is a facility-wide engineering and governance function, addressing temperature control, circulation, elimination of dead legs, outlet management, disinfectant residual, and the response to a positive result or a case. It is not a laboratory testing schedule, and periodic sampling without the underlying control measures does not constitute a water management program.

In the specific context of endoscope reprocessing, L. pneumophila is not a routine final rinse water target and should not be presented as one. It is a fastidious organism requiring selective media containing L-cysteine and prolonged incubation, it is not recovered by the standard total viable count and indicator methods applied to rinse water, and the reprocessing pathway does not generate the inhalational or aspiration exposure that causes legionellosis. Its relevance to a reprocessing department is upstream and facility-wide: the same building water system that supplies the reprocessing plant also supplies showers, taps and other aerosol-generating outlets. Any detection of Legionella anywhere in a healthcare water system should be escalated under the facility's water management program, and reprocessing water treatment should not be relied upon as a substitute for that program.

Relevance in endoscopy and reprocessing

Legionella pneumophila has no established role in flexible endoscope reprocessing, and this should be stated plainly rather than implied by omission. It is not a target organism in endoscope final rinse water testing, it is not detected by the total viable count and indicator methods used for that purpose, and the exposure mechanism that causes legionellosis, namely inhalation of aerosol or aspiration of water into the lower respiratory tract, does not arise from the passage of a reprocessed gastrointestinal endoscope. There is no credible body of literature attributing legionellosis to endoscope reprocessing, and a reprocessing service should not be presented with Legionella testing as though it were a rinse water compliance requirement.

What a detection does indicate is a problem in the building water system, and that is a matter of real consequence for the reprocessing department even though the department is not the exposure route. The mains and warm water services that feed the reverse osmosis plant are part of the same premise plumbing that feeds showers, taps, ice machines and any aerosol-generating equipment in the facility. A Legionella-positive result from anywhere in that system is evidence of conditions, meaning stagnation, inadequate temperature control, sediment, scale or depleted disinfectant residual, that equally favour Pseudomonas, Serratia, non-tuberculous mycobacteria and other organisms that are directly relevant to reprocessing. In this sense Legionella functions as a sentinel for water system control failure rather than as a reprocessing hazard in its own right. Reprocessing departments are also affected operationally, since remedial measures such as thermal shock disinfection, hyperchlorination or point-of-use filtration applied to a building water system will change the feed to the treatment plant and may require the plant to be isolated, flushed and revalidated.

One genuine clinical intersection exists in bronchoscopy, though it concerns non-sterile water use rather than reprocessing chemistry. Where tap water is used for rinsing bronchoscopes, for topical anaesthesia, or for lavage, waterborne organisms including Legionella and non-tuberculous mycobacteria can be introduced directly into the lower respiratory tract, which is precisely the exposure route legionellosis requires. Bronchoscopy-related pseudo-outbreaks arising from non-sterile water use are documented for other waterborne organisms, and the same principle applies here. The control is categorical: tap water must not be used at any stage after high-level disinfection of a bronchoscope, nor in any solution instilled into the airway. For CSD and dental services the parallel concern is aerosol generation from colonised outlets and, in dental practice, the waterline and handpiece circuits, which are within scope of a facility water management program rather than of device reprocessing validation.

Interpreting a detection

A Legionella-positive result is not a routine outcome of endoscope final rinse water surveillance, because the organism is not sought by the standard methods. If Legionella has been reported, it is almost always because a directed test was requested, typically as part of a facility water management program, an investigation of a suspected case, or a commissioning or remediation exercise. The first step on receiving such a report is therefore to establish what was actually sampled and why: a cooling tower, a calorifier, a shower outlet, a warm water return, an incoming main, or a point within the reprocessing water train. The interpretation and the required response differ substantially between these.

Sampling and handling artefact is a much smaller consideration for Legionella than for other organisms, since detection requires selective culture on cysteine-supplemented media or a specific molecular assay and the organism is not a plausible incidental contaminant. The more common interpretive difficulties run the other way. Culture underestimates the true burden because viable but non-culturable cells and organisms sheltered within amoebae are not recovered, so a negative or low result does not demonstrate a controlled system. Molecular methods detect non-viable organisms and typically return higher numbers than culture. Results are also affected by whether the sample was a first-draw or post-flush sample and whether a neutraliser was used, and these details must be known before any conclusion is drawn.

The checks that follow a positive result belong to the water management program rather than to the reprocessing service, but the reprocessing manager should understand and be able to interrogate them. They comprise temperature verification at outlets and at storage, confirming that hot water is delivered and returned above the design threshold and cold water held below it; identification of stagnation, dead legs, capped spurs, oversized storage and infrequently used outlets; assessment of scale, sediment, corrosion and materials that support biofilm; verification of disinfectant residual where a secondary treatment is in place; and review of recent building works, occupancy changes or shutdown periods, since reduced occupancy is a recognised precipitant. A single positive at a single outlet is managed differently from positives across multiple outlets or from a positive at a central asset such as a calorifier or storage tank, the latter indicating system-wide rather than local colonisation. Trend data over successive rounds is more informative than any single result.

Escalation is not discretionary. Any Legionella detection in a healthcare water system should be reported through the facility water management program and to infection prevention, and in Australia any confirmed case of legionellosis is notifiable to the state or territory health authority, with cooling tower systems separately regulated under public health legislation. Where a healthcare-associated case is suspected, the response includes clinical case finding, retention of clinical and environmental isolates for typing, restriction of exposure for high-risk patients, and consideration of point-of-use filtration pending remediation. For the reprocessing department specifically, the correct action on learning of a facility Legionella problem is to confirm with engineering whether the feed to the treatment plant is affected, whether remedial dosing or thermal treatment will pass through the plant, and whether the plant requires isolation, flushing and revalidation before reprocessing resumes. Reprocessing water treatment should never be offered as a mitigation for a building water system that is out of control.

Antimicrobial resistance

Antimicrobial resistance is not a significant clinical issue for L. pneumophila, which remains generally susceptible to macrolides, fluoroquinolones and other intracellularly active agents. Because the organism replicates within host cells, effective therapy requires agents that achieve adequate intracellular concentrations, and beta-lactams are ineffective in vivo despite any in vitro activity. Isolated reports of reduced fluoroquinolone susceptibility arising during treatment exist but do not currently constitute a meaningful clinical problem, and routine susceptibility testing is not performed.

Of greater practical importance is its environmental resilience. Association with protozoan hosts and biofilm confers substantial protection against chlorine and other residual disinfectants at the concentrations typically maintained in building water systems. Organisms replicating within amoebae are shielded from biocide by the host cell, and cells released in amoebal vesicles retain that protection; organisms within mature multi-species biofilm are additionally protected by restricted diffusion and by reaction of the biocide with the matrix. Scale, sediment, corrosion products and certain plumbing materials all increase this protective effect, which is why physically dirty systems are harder to control than clean ones at the same disinfectant dose.

Control therefore depends on temperature management, elimination of stagnation and engineering intervention rather than on disinfectant alone. The measures with the strongest evidence are maintaining hot water above and cold water below the growth range throughout the system including at every outlet, ensuring genuine circulation with no dead legs or blind branches, removing sediment and scale from storage vessels and calorifiers, flushing infrequently used outlets on a defined schedule, and selecting materials that do not support biofilm growth. Secondary disinfection systems, whether chlorine dioxide, monochloramine, copper-silver ionisation or hyperchlorination, are adjuncts to these measures rather than replacements for them, and each has known limitations including loss of efficacy in poorly circulated sections and, for some systems, reduced effectiveness over time. Point-of-use filtration provides an immediate barrier at specific outlets and is appropriate for protecting high-risk patients during remediation, but it does not treat the system and its filters have defined service lives that must be respected.

Sources and further reading

  1. Centers for Disease Control and Prevention. Water management in healthcare facilities. https://www.cdc.gov/control-legionella/php/healthcare/water-management.html
  2. Centers for Disease Control and Prevention. Developing a water management program to reduce Legionella growth and spread in buildings: a practical guide to implementing industry standards. https://www.cdc.gov/control-legionella/media/pdfs/toolkit.pdf
  3. Centers for Disease Control and Prevention. Overview of water management programs. https://www.cdc.gov/control-legionella/php/wmp/index.html
  4. World Health Organization. Legionellosis fact sheet. https://www.who.int/news-room/fact-sheets/detail/legionellosis
  5. Australian Government Department of Health and Aged Care. Legionellosis. https://www.health.gov.au/diseases/legionellosis
  6. Standards Australia. AS/NZS 3666 Air-handling and water systems of buildings - Microbial control.